Global Mucosal Atomization Device Market Surges toward a Projected USD 1.11 Billion by 2034, Fueled by Demand for Non-invasive Drug Delivery Solutions in Healthcare | Future Market Insights, Inc.

July 16, 2024 6:00 AM

The global mucosal atomization device market is estimated to be worth USD 570.52 million in 2024, according to Future Market Insights' (FMI) latest report. It is anticipated to expand to USD 1.11 billion by 2034. Sales of mucosal atomization devices are forecasted to experience a steady rise, with a projected CAGR of 6.9% through 2034.The market is expanding significantly due to various factors. One of the primary drivers is the increasing...

Read more

SPS Health Acquires Mideast Delivery Solutions to Enhance Healthcare Delivery Network

July 15, 2024 4:55 PM

MILWAUKEE, WI / ACCESSWIRE / July 15, 2024 / SPS Health, a leading innovator in acute and post-acute pharmacy solutions, is proud to announce the acquisition of Mideast Delivery Solutions, a prominent provider of specialized courier services to the long-term care pharmacy industry. This strategic acquisition is set to significantly enhance the capabilities of SPS Health's logistics business unit, StatimRX, further solidifying its position as a...

Read more

Avant Brands Reports Continued Growth in Q2 2024 Financial Results

July 15, 2024 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today released its financial results for the second quarter ended May 31, 2024 ("Q2 2024"). The Company achieved significant financial milestones driven by strategic international expansion and operational improvements.In Q2 2024, Avant Brands reports records across key financial metrics,...

Read more

NHI Announces Second Quarter 2024 Earnings Release and Conference Call Date

July 15, 2024 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the second quarter ended June 30, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, August 6, 2024, and will host a conference call on the following day, Wednesday, August 7, 2024, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the...

Read more

B2B Pharmacy Services Now Available from Canada Pharmacy

July 15, 2024 4:00 PM

Established Canadian online pharmacy now partnering with smaller pharmaciesVICTORIA, BC / ACCESSWIRE / July 15, 2024 / Logistic and operational challenges are increasingly the norm for businesses of all types, and notably so since the pandemic. Drug shortages may be less connected to the fallout from it, but they are a reality now for both consumers and the pharmacies that fill their prescriptions. Some may be more difficult to fill than others,...

Read more

Season One of 'Baby Boxes' is Coming in Hot

July 15, 2024 11:00 AM

Meet the Families Behind Safe Haven Baby BoxesWOODBURN, IN / ACCESSWIRE / July 15, 2024 / Safe Haven Baby Boxes recently announced the launch of its episodic YouTube series, "Baby Boxes." The brand-new series takes viewers behind the scenes, giving them an exclusive look at what it takes to create the life-saving Safe Haven Baby Boxes.Founded in 2015 by Monica Kelsey, the Safe Haven Baby Boxes organization was established to provide a safe and...

Read more

Complete Care Lakeview Announces Name Change to Complete Care Wayne Hills Rehab & Respiratory Center

July 15, 2024 8:45 AM

WAYNE, NJ / ACCESSWIRE / July 15, 2024 / Complete Care Lakeview, a leading provider of skilled nursing care in Wayne, NJ, is pleased to announce a significant milestone in its history. Effective today, the facility will be operating under a new name: Complete Care Wayne Hills Rehab and Respiratory Center. Complete Care Wayne Hills This change comes as part of Complete Care's ongoing commitment to enhancing their services and better aligning with...

Read more

Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform

July 15, 2024 8:00 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a proof-of-concept study with Gubra A/S ("Gubra") in a high-fat, diet-induced obese ("DIO") mouse model to explore the potential future use of the MODD1 pump platform to assist patients who struggle with tolerability,...

Read more

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

July 15, 2024 7:00 AM

ORLANDO, FL / ACCESSWIRE / July 15, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on July 9, 2024, for trademark application Serial Number 98117984, covering the mark "AVERSA™." The Notice of Allowance signifies that the USPTO is expected to grant a trademark registration for...

Read more

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

July 15, 2024 7:00 AM

MIAMI, FL / ACCESSWIRE / July 15, 2024 / MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical development company, today announced promising new findings from recent preclinical studies of its novel oral pharmaceutical marijuana analog, MIRA-55, which is being studied as a potential treatment for anxiety and cognitive decline.The new data confirms MIRA's earlier beliefs regarding MIRA-55's...

Read more

Encision Reports Fourth Quarter Fiscal Year 2024 Results

July 15, 2024 5:00 AM

Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2024 fourth quarter that ended March 31, 2024.The Company posted quarterly net revenue of $1.53 million for a quarterly net loss of $409 thousand, or $(0.03) per diluted share. These results compare to net...

Read more

Hospital Español Auxilio Mutuo De Puerto Rico, Inc. Reports Network Breach

July 12, 2024 9:00 PM

Important Notice About a Privacy MatterSAN JUAN, PUERTO RICO / ACCESSWIRE / July 12, 2024 / On or around September 24, 2023, Hospital Español Auxilio Mutuo de Puerto Rico, Inc. ("Hospital Auxilio Mutuo") discovered an unauthorized access on its network. Upon discovery, Hospital Auxilio Mutuo took immediate action and enlisted the help of experts, retaining outside counsel and IT forensic specialists to determine the cause and extent of the...

Read more

Angle PLC Announces Standard Form for Notification of Major Holdings

July 12, 2024 11:35 AM

TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:ANGLE plc1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)Non-UK issuer 2. Reason for the notification (please mark the...

Read more

Allure Esthetic Resolves Lawsuit With Washington Attorney General's Office

July 12, 2024 11:00 AM

Allure Esthetic settled claims with Washington's Attorney General's Office, in order to focus on their core mission of providing care to patients and serving their community.SEATTLE, WA / ACCESSWIRE / July 12, 2024 / Allure Esthetic et al., a small family-run medical practice, is pleased to have resolved its case with the Washington's Attorney General's Office. The cooperative settlement, while not admitting fault and resolving claims asserted...

Read more

EIR Supplements Introduces Longevity Formula for Cellular Health and Wellness

July 12, 2024 9:00 AM

MIAMI, FL / ACCESSWIRE / July 12, 2024 / EIR Supplements, a leading innovator in health and wellness, is proud to announce the launch of its flagship product, Longevity Formula. This groundbreaking supplement is designed to support cellular health and overall vitality through advanced genetic research and premium natural ingredients. Longevity Formula is the result of extensive scientific research and development by a team of leading scientists...

Read more

Interim Report January - June 2024

July 12, 2024 1:50 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / July 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Second quarter 2024 (Apr 1 - Jun 30) • Net sales amounted to SEK 210.3 million (154.6), corresponding to growth of 36 percent in SEK and 35 percent in local currencies. Organic growth accounted for 35 percent, currency effect 1 percent.• All business areas delivered underlying organic growth adjusted for currency effects: Thoracic disposables 40...

Read more

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

July 11, 2024 4:05 PM

Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on Thursday, July 18, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic)...

Read more

ANY LAB TEST NOW Owner Crowned a Rock Star by Franchise Business Review

July 11, 2024 3:05 PM

ANY LAB TEST NOW®, the nation's leading provider of direct access lab testing, is celebrating a tremendous honor for its El Paso, Texas franchise location. Franchise Business Review (FBR) has named El Paso franchise owner Royal Banks as one of the research firm's 2024 Franchise Rock Stars in the Veterans category.Banks, a U.S. Army veteran, was among hundreds of nominations submitted by franchisors across the nation. At the core of Banks'...

Read more

Promising Data on Transdermal Obesity Formulations Announced by Skinvisible

July 11, 2024 12:15 PM

Results Demonstrate Significant Transdermal Performance of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Using Invisicare TechnologyLAS VEGAS, NV / ACCESSWIRE / July 11, 2024 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical pharmaceutical research and development company, today announced exciting data demonstrating its transdermal delivery of obesity drugs (and other glucose-...

Read more

AGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in Pathology

July 11, 2024 11:45 AM

MORTSEL, BELGIUM / ACCESSWIRE / July 11, 2024 / AGFA HealthCare, a global leader in healthcare imaging management solutions, is pleased to announce that Enterprise Imaging for Pathology, powered by Corista DP3®, is now available in North America*. This specialty solution is built for Pathologists by Pathologists and healthcare software experts; enabling Pathologists to work comfortably in their familiar flow. This sophisticated solution...

Read more